Methotrexate in rheumatoid arthritis: Optimizing therapy among different formulations. Current and emerging paradigms

Clinical Therapeutics

Volumn 36, Issue 3, 2014, Pages 427-435

  Cipriani, Paola ^a   Ruscitti, Piero ^a   Carubbi, Francesco ^a   Liakouli, Vasiliki ^a   Giacomelli, Roberto ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

disease modifying anti rheumatic drugs; Methotrexate; rheumatoid arthritis; therapeutic strategy

Indexed keywords

METHOTREXATE; ANTIRHEUMATIC AGENT;

ACUTE TOXICITY; ALOPECIA; ANOREXIA; ARTICLE; CHRONIC TOXICITY; COCHRANE LIBRARY; DERMATITIS; DIARRHEA; DISEASE EXACERBATION; DRUG BIOAVAILABILITY; DRUG DOSE ESCALATION; DRUG FORMULATION; DRUG MECHANISM; GYNECOMASTIA; HEADACHE; HUMAN; HYPERTRANSAMINASEMIA; INFECTION; INTERSTITIAL PNEUMONIA; LEUKOPENIA; LIVER CIRRHOSIS; MALAISE; MEDICAL SUBJECT HEADINGS; MEDLINE; META ANALYSIS; MUCOSA INFLAMMATION; NAUSEA; NEPHROTOXICITY; OBSERVATIONAL STUDY; OLIGOSPERMIA; OPTIMAL DRUG DOSE; PATIENT PREFERENCE; PHOTOSENSITIVITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; VERTIGO; ARTHRITIS, RHEUMATOID; BIOAVAILABILITY; DRUG ADMINISTRATION ROUTE; INFUSION; INTRAMUSCULAR DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL AVAILABILITY; DRUG ADMINISTRATION ROUTES; HUMANS; INFUSIONS, PARENTERAL; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; METHOTREXATE; QUALITY OF LIFE;

EID: 84896395527     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2014.01.014     Document Type: Review

References (57)

1. G. Pasero, and P. Marson A short history of anti-rheumatic therapy - VI. Rheumatoid arthritis drugs [in Italian] Reumatismo 63 2011 111 123
2. J.M. Smith, D.B. Cosulich, and M.E. Hultquist et al. The chemistry of certain pteroylglutamic acid antagonist Trans NY Acad Sci 10 1948 82 83
3. G. Pasero, and P. Marson A short story of anti-rheumatic therapy. VIII. The immunodepressants [In Italian] Reumatismo 64 2012 44 54
4. R.T. Hoffmeister Methotrexate therapy in rheumatoid arthritis. 15 years' experience Am J Med 75 1983 69 73
5. T. Pincus, Y. Yazici, and T. Sokka et al. Methotrexate as the anchor drug for the treatment of early rheumatoid arthritis Clin Exp Rheumatol 21 2003 S179 S185
6. R. Giacomelli, P. Cipriani, and M. Matucci Cerinic et al. Combination therapy with cyclosporine and methotrexate in patients with early rheumatoid arthritis soon inhibits TNFalpha production without decreasing TNFalpha mRNA levels. An in vivo and in vitro study Clin Exp Rheumatol 20 2002 365 372
7. E. Zintzaras, I.J. Dahabreh, and S. Giannouli et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens Clin Ther 30 2008 1939 1955
8. Y. Zhuang, Z. Xu, and B. Frederick et al. Golimumab pharmacokinetics after repeated subcutaneous and intravenous administrations in patients with rheumatoid arthritis and the effect of concomitant methotrexate: an open-label, randomized study Clin Ther 34 2012 77 90
9. J.M. Wong, and J.M. Esdaile Methotrexate in systemic lupus erythematosus Lupus 14 2005 101 105
10. K. Visser, W. Katchamart, and E. Loza et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative Ann Rheum Dis 68 2009 1086 1093
11. F. De Leonardis, S. Alivernini, and E. Bonacci et al. Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the "3E initiative" [in Italian] Reumatismo 62 2010 34 45
12. J.W. McDonald, D.J. Tsoulis, and J.K. Macdonald et al. Methotrexate for induction of remission in refractory Crohn's disease Cochrane Database Syst Rev 12 2012 CD003459
13. M. van Tulder, A. Furlan, C. Bombardier, and L. Bouter Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group Spine 28 2003 1290 1299
14. Oxford Centre for Evidence-Based Medicine. Levels of evidence. http://www.cebm.net/index.aspx?o=1025. Accessed January 2, 2013
15. H. Tian, and B.N. Cronstein Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis Bull NYU Hosp Jt Dis 65 2007 168 173
16. J. Grim, J. Chládek, and J. Martínková Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases Clin Pharmacokinet 42 2003 139 151
17. S. Pavy, A. Constantin, and P. Thao et al. Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion Joint Bone Spine 73 2006 388 395
18. S. Pandya, A. Aggarwal, and R. Misra Methotrexate twice weekly vs once weekly in rheumatoid arthritis: a pilot double-blind, controlled study Rheumatol Int 22 2002 1 4
19. A.E. van Ede, R.F. Laan, and M.J. Rood et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study Arthritis Rheum 44 2001 1515 1524
20. A.E. van Ede, R.F. Laan, and H.J. Blom et al. Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity Semin Arthritis Rheum 27 1998 277 292
21. A.T. Borchers, C.L. Keen, G.S. Cheema, and M.E. Gershwin The use of methotrexate in rheumatoid arthritis Semin Arthritis Rheum 34 2004 465 483
22. S.L. Morgan, J.E. Baggott, and W.H. Vaughn et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial Ann Intern Med 121 1994 833 841
23. B. Shea, M.V. Swinden, and E. Tanjong Ghogomu et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis Cochrane Database Syst Rev 5 2013 CD000951
24. P.S. Hanrahan, and A.S. Russell Concurrent use of folinic acid and methotrexate in rheumatoid arthritis J Rheumatol 15 1988 1078 1080
25. D.A. Joyce, R.K. Will, and D.M. Hoffman et al. Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid Ann Rheum Dis 50 1991 913 914
26. S. Price, C. James, and C. Deighton Methotrexate use and alcohol Clin Exp Rheumatol 28 Suppl 61 2010 S114 S116
27. M.Y. Mok, W.L. Ng, and M.F. Yuen et al. Safety of disease modifying anti-rheumatic agents in rheumatoid arthritis patients with chronic viral hepatitis Clin Exp Rheumatol 18 2000 363 368
28. D.M. Grennan, J. Gray, J. Loudon, and S. Fear Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery Ann Rheum Dis 60 2001 214 217
29. E.F. Chakravarty, D. Sanchez-Yamamoto, and T.M. Bush The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes J Rheumatol 30 2003 241 246
30. B. Lewden, T. Vial, and E. Elefant et al. Low dose methotrexate in the first trimester of pregnancy: results of a French collaborative study J Rheumatol 31 2004 2360 2365
31. B. Combe, C. Didry, and M. Gutierrez et al. Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis Eur J Med 2 1993 153 156
32. G.S. Alarcón, J.M. Kremer, and M. Macaluso et al. Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group Ann Intern Med 127 1997 356 364
33. J.M. Kremer, G.S. Alarcon, and M.E. Weinblatt et al. Clinical, laboratory, radiographic, and histopathologic features of methotrexate- associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review Arthritis Rheum 40 1997 1829 1837
34. J.M. Kremer, and C.T. Phelps Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months Arthritis Rheum 35 1992 138 145
35. J.A. van Nies, Z. de Jong, and A.H. van der Helm-van Mil et al. Improved treatment strategies reduce the increased mortality risk in early RA patients Rheumatology (Oxford) 49 2010 2210 2216
36. M. van den Broek, W.F. Lems, and C.F. Allaart BeSt practice: the success of early-targeted treatment in rheumatoid arthritis Clin Exp Rheumatol 30 4 Suppl 73 2012 S35 S38
37. M.E. Weinblatt, J.S. Coblyn, and D.A. Fox et al. Efficacy of low-dose methotrexate in rheumatoid arthritis N Engl J Med 312 1985 818 822
38. E.L. Hobl, R.M. Mader, and B. Jilma et al. A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis Clin Ther 34 2012 1195 1203
39. M. Patanè, M. Ciriaco, and S. Chimirri et al. Interactions among low dose of methotrexate and drugs used in the treatment of rheumatoid arthritis Adv Pharmacol Sci 2013 2013 313858
40. V. Chungi, D. Bourne, and L. Dittert Drug absorption VIII: kinetics of GI absorption of methotrexate J Pharm Sci 67 1978 560 561
41. J.M. Dalrymple, L.K. Stamp, and J.L. O'Donnell et al. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis Arthritis Rheum 11 2008 3299 3308
42. R.A. Hamilton, and J.M. Kremer Why intramuscular methotrexate may be more efficacious than oral dosing in patients with rheumatoid arthritis Br J Rheumatol 36 1997 86 90
43. J. Braun, P. Kaestner, and P. Flaxenberg et al. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial Arthritis Rheum 58 2008 73 81
44. L. Rutkowska-Sak, M. Rell-Bakalarska, and B. Lisowska Oral vs. subcutaneous low-dose methotrexate treatment in reducing gastrointestinal side effects Reumatologia 47 2009 207 211
45. U. Müller-Ladner, K. Rockwitz, and J. Brandt-Jürgens et al. Tolerability and patient/physician satisfaction with subcutaneously administered methotrexate provided in two formulations of different drug concentrations in patients with rheumatoid arthritis Open Rheumatol J 4 2010 15 22
46. P.J. Brooks, W.J. Spruill, and R.C. Parish et al. Pharmacokinetics of methotrexate administered by intramuscular and subcutaneous injections in patients with rheumatoid arthritis Arthritis Rheum 33 1990 91 94
47. F. Striesow, and A. Brandt Preference, satisfaction and usability of subcutaneously administered methotrexate for rheumatoid arthritis or psoriatic arthritis: results of a postmarketing surveillance study with a high-concentration formulation Ther Adv Musculoskelet Dis 4 2012 3 9
48. M. Hoekstra, C. Haagsma, and C. Neef et al. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis J Rheumatol 31 2004 645 648
49. L.K. Stamp, M.L. Barclay, and J.L. O'Donnell et al. Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis J Rheumatol 38 2011 2540 2547
50. S.M. Verstappen, J.W. Jacobs, and M.J. van der Veen et al. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial) Ann Rheum Dis 66 2007 1443 1449
51. A. Rozin, D. Schapira, and A. Balbir-Gurman et al. Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate Ann Rheum Dis 61 2002 756 757
52. J. Wegrzyn, P. Adeleine, and P. Miossec Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis Ann Rheum Dis 63 2004 1232 1234
53. J. Braun, P. Kästner, and P. Flaxenberg et al. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial Arthritis Rheum 58 2008 73 81
54. K. Alsufyani, O. Ortiz-Alvarez, and D.A. Cabral et al. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate J Rheumatol 31 2004 179 182
55. N. Ruperto, D.J. Lovell, and R. Cuttica et al. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension Ann Rheum Dis 69 2010 718 722
56. G. Mouterde, A. Baillet, and C. Gaujoux-Viala et al. Optimizing methotrexate therapy in rheumatoid arthritis: a systematic literature review Joint Bone Spine 78 2011 587 592
57. K. Visser, and D. van der Heijde Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature Ann Rheum Dis 68 2009 1094 1099